Entera Bio files S-3 registration for resale of shares and warrants from December private placement

Entera Bio Ltd.

Filed registration statement on Form S-3 on Feb 2, 2024 per registration rights agreement from Dec 22, 2023 private placement.
Securities to be registered include ordinary shares and warrants (exercisable at $5.85 per share) issued to accredited investors.
Registration enables resale of private placement securities; does not constitute an offer to sell or solicitation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.